A - 28 BeneVision N22/N19 Patient Monitor Operator’s Manual
Rise time
(10% ~ 90%)
gas sample flow rate 120ml/min, using the DRYLINE
TM
watertrap and neonatal
DRYLINE
TM
sampling line (2.5m):
CO
2
N
2
O
O
2
Hal, Iso, Sev, Des
Enf
≤250 ms
≤250 ms
≤600 ms (for O
2
concentration from 15 to
21%)
≤300 ms
≤350 ms
gas sample flow rate 200ml/min, using the DRYLINE
TM
water trap and adult
DRYLINE
TM
sampling line (2.5m):
CO
2
N
2
O
O
2
Hal, Iso, Sev, Des
Enf
≤250 ms
≤250 ms
≤500 ms
≤300 ms
≤350 ms
Delay time <4 s
Response time Measured with a neonatal watertrap and a 2.5-meter neonatal sampling line:
120 ml/min:
CO
2
:
N
2
O:
O
2
:
HAL, ISO, SEV, DES, ENF:
≤4s
≤4.2s
≤4s
≤4.4s
Measured with an adult watertrap and a 2.5-meter adult sampling line:
120 ml/min:
CO
2
:
N
2
O:
HAL, ISO, SEV, DES, ENF:
ENF:
O
2
:
≤4.2s
≤4.3s
≤4.5s
≤4s
≤4s
Anesthetic agent limit Primary anesthetic agent
In full accuracy mode: 0.15%,
In ISO accuracy mode: 0.3%
Secondary anesthetic agent:
In full accuracy mode: 5% of primary agent if primary agent is greater than
10%, 0.3% if primary agent is less than or equal to 10%.
Data sample rate 25 Hz
Inaccuracy specifications are affected by the breath rate and I:E change. The end-tidal gas reading is within specification for
breath rate below 15BPM and I:E ratio smaller than 1:1 relative to the gas readings without breath; Add ±6%REL to
inaccuracy for HAL and O
2
for breath rate larger than 15 BPM; Add ±6%REL to inaccuracy for all gases for breath rate larger
than 30 BPM (inaccuracy for HAL and O
2
are unspecified in this case); inaccuracy is unspecified for breath rate larger than 60
BPM.
Effect of interference gases on AG measurements
Gas
Concentrati
on(%)
Quantitive effect(%ABS)3)
CO
2
N
2
O
Agent 1)
O
2
CO
2
//0.100.2
N
2
O/0.1/0.10.2
Agent 1) 2) / 0.1 0.1 0.1 1